Alexion Pharmaceuticals has announced an additional €100 million investment in an expansion of its Athlone operations which will result in the creation of 50 additional jobs for Athlone.
The new investment will bring total employment at the facility to more than 100 people. The investment will see the construction of a new biologics manufacturing facility at the site.
“Alexion is delighted to announce this additional expansion to our existing Athlone site as we deliver upon our mission to transform the lives of patients with ultra-rare diseases,” said Julie O’Neill, executive vice president of global operations at Alexion.
“Ireland is a key location for Alexion’s global operations and we are committed to further developing our manufacturing facilities in the country to support increasing production needs of our highly innovative and life-transforming therapies.”
The new manufacturing facility demonstrates Alexion’s continued commitment to Ireland and to Athlone since first announcing a presence in the area. The current Athlone site houses a vial fill-finish facility.
To view Keith’s Renewable Energy Photography, click here.
To view Keith’s Business Photography, click here.
To view Keith’s Commercial photography, click here.
To view Keith’s videos, click here.